Recent News
Ruth O’Keefe Promoted to ThinkGenetic Vice President, Marketing and Patient Advocacy
BOSTON, Ma., April 2, 2019 (Newswire.com) – ThinkGenetic, Inc. (www.ThinkGenetic.com), is excited to announce the promotion of Ruth O’Keefe to Vice President, Marketing and Patient Advocacy. ThinkGenetic, the creators of… CONTINUE
MetroWest Daily News: Sudbury startup aids in diagnosing genetic conditions
Original article: https://www.metrowestdailynews.com/news/20190307/sudbury-startup-aids-in-diagnosing-genetic-conditions By Zane Razzaq Daily News staff SUDBURY – With the average patient struggling to find a diagnosis for a genetic condition for several years, a Sudbury family is… CONTINUE
Big News for ThinkGenetic Supporters – Angel Funding Round is Closed
In a very exciting announcement from the news desk, ThinkGenetic announced the closure of its $1.5M Angel Funding round. (See the full announcement here.) When asked about the incredible accomplishment,… CONTINUE
ThinkGenetic in the Press
ThinkGenetic Closes $1.5M Angel Round of Funding
LAFAYETTE, La. – February 19, 2019 – (Newswire.com) – ThinkGenetic, Inc. (www.ThinkGenetic.com), makers of an artificial intelligence-driven SymptomMatcher™ for genetic disorders, today announced the successful close of its angel round of funding… CONTINUE
ThinkGenetic Declared a Top Digital Health Startup
ThinkGenetic paired with Shire Plc. and Massachusetts eHealth Institute to support development of new artificial intelligence diagnostic aide as part of PULSE@MassChallenge program. BOSTON, MA (PRWEB) JANUARY 30, 2018 –… CONTINUE
ThinkGenetic Continues to Shorten Time to Diagnosis with Help from Stealth BioTherapeutics
Innovative Biopharmaceutical Company Supports Addition of Mitochondrial Genetic Diseases in ThinkGenetic Knowledge Base BOSTON, MA (PRWEB) JANUARY 16, 2018 – ThinkGenetic, Inc. (www.ThinkGenetic.com), makers of an artificial intelligence driven-SymptomMatcherTM for… CONTINUE